Company intelligence / Profile preview

TriNutra

Ownership: Private
Development stage: Commercial

Overview

TriNutra has developed and commercialized patented, standardized black seed oil ingredients—most notably ThymoQuin—demonstrated in published clinical trials to have benefits for inflammation, metabolic health, skin appearance, and general wellness. The company holds global patents for composition, stability, bioavailability, and use of its ingredients. Clinical results cited include improved efficacy and stability compared to conventional Nigella sativa oils. Pipeline includes additional synergistic formulations with other botanicals as indicated by patent activity.

Therapeutic areas: Metabolic DisordersImmunologyOtherDermatologyNeurology
Modalities: Small molecule (plant-derived bioactives)Oil-based formulation (nutraceutical/functional ingredient)
Industry: Food & Nutrition

Drug pipeline

5 assets

ThymoQuin

Commercial

Indications: Metabolic disorders, Obesity

4 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on TriNutra.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TriNutra.

Explore the full profile